Astrana Health (NASDAQ:ASTH) Upgraded to “Overweight” at Barclays

Astrana Health (NASDAQ:ASTH) was upgraded by analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday. The brokerage presently has a $50.00 price target on the stock. Barclays‘s target price suggests a potential upside of 32.10% from the company’s previous close.

A number of other analysts have also recently commented on ASTH. Truist Financial boosted their target price on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Robert W. Baird set a $45.00 target price on shares of Astrana Health in a research note on Friday, May 8th. BTIG Research boosted their target price on shares of Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Needham & Company LLC boosted their target price on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Finally, Weiss Ratings raised shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $45.00.

Astrana Health Price Performance

ASTH stock opened at $37.85 on Tuesday. The stock has a market capitalization of $2.11 billion, a P/E ratio of 62.05 and a beta of 0.98. The firm has a 50-day simple moving average of $30.99 and a 200-day simple moving average of $26.15. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. Astrana Health has a 52 week low of $18.08 and a 52 week high of $39.93.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The business had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company’s quarterly revenue was up 55.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.42 earnings per share. Equities analysts forecast that Astrana Health will post 1.25 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Several large investors have recently bought and sold shares of ASTH. Signaturefd LLC grew its stake in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after acquiring an additional 388 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio acquired a new position in Astrana Health in the 4th quarter valued at about $40,000. Tower Research Capital LLC TRC boosted its holdings in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the last quarter. Finally, State of Wyoming acquired a new position in Astrana Health in the 2nd quarter valued at about $132,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.